These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15131756)

  • 1. The relationship between glycemic control and plasma vascular endothelial growth factor and endothelin-1 concentration in diabetic patients.
    Kakizawa H; Itoh M; Itoh Y; Imamura S; Ishiwata Y; Matsumoto T; Yamamoto K; Kato T; Ono Y; Nagata M; Hayakawa N; Suzuki A; Goto Y; Oda N
    Metabolism; 2004 May; 53(5):550-5. PubMed ID: 15131756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of vascular endothelial growth factor plasma levels and glycemic control in patients with diabetic retinopathy.
    Zehetner C; Kirchmair R; Kralinger M; Kieselbach G
    Acta Ophthalmol; 2013 Sep; 91(6):e470-3. PubMed ID: 23452413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes of plasma endothelin-1 and vascular endothelial growth factor in diabetic retinopathy and the clinical application value thereof].
    Zhu H; Shi CH
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(40):2837-9. PubMed ID: 18167288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relation between plasma endothelin-1 levels and metabolic control, risk factors, treatment modalities, and diabetic microangiopathy in patients with Type 2 diabetes mellitus.
    Ak G; Buyukberber S; Sevinc A; Turk HM; Ates M; Sari R; Savli H; Cigli A
    J Diabetes Complications; 2001; 15(3):150-7. PubMed ID: 11358684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of insulin on plasma vascular endothelial growth factor in children with new-onset diabetes.
    Ashraf A; Mick G; Meleth S; Abdullatif H; Wang X; McCormick K
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4920-3. PubMed ID: 15914522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased plasma urotensin-II levels are associated with diabetic retinopathy and carotid atherosclerosis in Type 2 diabetes.
    Suguro T; Watanabe T; Kodate S; Xu G; Hirano T; Adachi M; Miyazaki A
    Clin Sci (Lond); 2008 Dec; 115(11):327-34. PubMed ID: 18338983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: relation to glycaemic control and microvascular complications.
    Chiarelli F; Spagnoli A; Basciani F; Tumini S; Mezzetti A; Cipollone F; Cuccurullo F; Morgese G; Verrotti A
    Diabet Med; 2000 Sep; 17(9):650-6. PubMed ID: 11051284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of osteoprotegerin and vascular endothelial growth factor in normoalbuminuric Type 1 diabetic and control subjects.
    Esteghamati A; Arefzadeh A; Zandieh A; Salehi Sadaghiani M; Noshad S; Nakhjavani M
    J Endocrinol Invest; 2013; 36(7):474-7. PubMed ID: 23877020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor level in the serum of diabetic patients with retinopathy.
    Cavusoglu AC; Bilgili S; Alaluf A; Doğan A; Yilmaz F; Aslanca D; Karaca B; Yüksel B; Topaloglu E
    Ann Ophthalmol (Skokie); 2007; 39(3):205-8. PubMed ID: 18025626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VEGF levels in plasma in relation to platelet activation, glycemic control, and microvascular complications in type 1 diabetes.
    Schlingemann RO; Van Noorden CJ; Diekman MJ; Tiller A; Meijers JC; Koolwijk P; Wiersinga WM
    Diabetes Care; 2013 Jun; 36(6):1629-34. PubMed ID: 23321217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitreous and plasma changes of endothelin-1, adrenomedullin and vascular endothelium growth factor in patients with proliferative diabetic retinopathy.
    Vingolo EM; Fragiotta S; Mafrici M; Cutini A; Marinelli C; Concistrè A; Iannucci G; Petramala L; Letizia C
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):662-668. PubMed ID: 28272719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum and Plasma Levels of Vascular Endothelial Growth Factors in Relation to Quality of Glucose Control, Biomarkers of Inflammation, and Diabetic Nephropathy.
    Hanefeld M; Appelt D; Engelmann K; Sandner D; Bornstein SR; Ganz X; Henkel E; Haase R; Birkenfeld AL
    Horm Metab Res; 2016 Aug; 48(8):529-34. PubMed ID: 27388431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between self-monitoring of blood glucose control and glycosylated haemoglobin in patients with type 2 diabetes with and without diabetic retinopathy.
    Ozmen B; Boyvada S
    J Diabetes Complications; 2003; 17(3):128-34. PubMed ID: 12738396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of Bushen Yiqi Huoxue prescription and its disassembled prescriptions on a diabetic retinopathy model in Sprague Dawley rats.
    Xie M; Deng L; Yu Y; Xie X; Zhang M
    Biomed Pharmacother; 2021 Jan; 133():110920. PubMed ID: 33232926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved glycemic control increases fasting plasma acylation-stimulating protein and decreases leptin concentrations in type II diabetic subjects.
    Ozata M; Gungor D; Turan M; Ozisik G; Bingol N; Ozgurtas T; Ozdemir IC
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3659-64. PubMed ID: 11502793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Increased Circulating Plasma Levels of Vascular Endothelial Growth Factor in Patients with Type 1 Diabetes Do Not Correlate to Metabolic Control.
    Singh K; Sandler S; Espes D
    J Diabetes Res; 2017; 2017():6192896. PubMed ID: 28421206
    [No Abstract]   [Full Text] [Related]  

  • 17. Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma.
    Paroni R; Ceriotti F; Galanello R; Battista Leoni G; Panico A; Scurati E; Paleari R; Chemello L; Quaino V; Scaldaferri L; Lapolla A; Mosca A
    Clin Biochem; 2007 Dec; 40(18):1398-405. PubMed ID: 17919531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Continuing care of patients with cardiovascular risk in general practice: diabetic patients and their care].
    Ilyés I; Jancsó Z; Kovács E; Márton H; Simay A
    Orv Hetil; 2005 Dec; 146(51):2581-8. PubMed ID: 16468612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycemic Variability and Diabetes Complications: Does It Matter? Of Course It Does!
    Hirsch IB
    Diabetes Care; 2015 Aug; 38(8):1610-4. PubMed ID: 26207054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum ferritin levels in poorly- and well-controlled diabetes mellitus.
    Canturk Z; Cetinarslan B; Tarkun I; Canturk NZ
    Endocr Res; 2003 Aug; 29(3):299-306. PubMed ID: 14535631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.